Atara Biotherapeutics, Inc. (Nasdaq: ATRA)commenced an underwritten public offering of $100,000,000 of its shares of common stock. In addition, Atara ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE